"The company has initiated necessary steps with the concerned authorities to resolve the matter. The impact of the said direction are contingent upon the outcome of the company's representations before the concerned authorities," Camlin Fine Sciences said in a statement issued during trading hours today.
On consolidated basis, the company's net profit advanced 429.8% to Rs 6.94 crore on a 10.4% rise in net sales to Rs 222.28 crore in Q2 September 2019 over Q2 September 2018.
Camlin Fine Sciences is a provider of high-quality shelf life extension solutions including antioxidants, aroma ingredients and performance chemicals.
